-56%

est. 2Y upside i

HealthcareSeries A

Rank

#257

Sector

Digital Health

Est. Liquidity

~3Y

Data Quality

Data: Medium

Mural Health presents a moderate upside opportunity for a job seeker, but with a higher risk profile due to its Series A stage and an estimated severe preference stack.

Last updated: March 10, 2026

Bull (30%)+400%

Mural Health's integrated patient-first platform gains significant market share by capitalizing on its fee-free payment options and global expansion, becoming a dominant player in clinical trial participant management. Strategic partnerships with top pharmaceutical companies and CROs drive revenue to over $50M by 2028, justifying a $300M+ valuation (5x current assumed valuation) at a 6x revenue multiple, well above the current assumed $60M valuation.

Base (55%)+50%

Mural Health continues to grow steadily, maintaining its niche in the clinical trial participant management market. It secures additional partnerships and expands its platform features, reaching approximately $20M in revenue by 2028. This growth supports a modest valuation increase to $90M (1.5x current assumed valuation), reflecting continued execution but facing competitive pressures.

Bear (15%)-80%

Dominant incumbents or well-funded competitors like Scout Clinical aggressively expand into Mural Health's core offerings, commoditizing its platform. Growth stalls, and the company struggles to differentiate, leading to a down round or acquisition at a significantly reduced valuation of $12M (0.2x current assumed valuation). Given the substantial liquidation preferences, common stock holders would likely receive little to no return.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Investors hold $21M in liquidation preferences ahead of common stock, representing 35% of the assumed $60M valuation.

Dilution Risk

high

As a Series A company, Mural Health will likely require additional funding rounds, which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for a Series A company of this size.

View all 4 open roles at Mural Health →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Mural Health's data — designed to show you've done your homework.

  • 1

    “Given the competitive landscape with players like Ripple Science and Scout Clinical, how does Mural Health plan to further strengthen its competitive moat and defend its market position over the next 2-3 years?”

  • 2

    “With an estimated $6M in revenue, what are the key growth levers and strategic initiatives Mural Health is focusing on to scale revenue significantly and achieve profitability within the next two years?”

  • 3

    “Considering the Series A funding and the potential for future dilution, how does Mural Health envision the path to liquidity for employees, and what is the company's philosophy on managing the equity value for its team members?”

Community

Valuation Sentiment

Our model estimates -56% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.